Reply to 'Endpoints in strategies to reduce polypharmacy'
Br J Clin Pharmacol
.
2017 Feb;83(2):434.
doi: 10.1111/bcp.13125.
Epub 2016 Oct 4.
Authors
Tim Johansson
1
,
Maria Flamm
1
,
Andreas Sönnichsen
2
Affiliations
1
Institute of General Practice, Family Medicine and Preventive Medicine, Paracelsus Medical University, Strubergasse 21, 5020, Salzburg, Austria.
2
Institute of General Practice and Family Medicine, University of Witten/Herdecke, Alfred-Herrhausen-Straße 50, 58448, Witten, Germany.
PMID:
27704600
PMCID:
PMC5237688
DOI:
10.1111/bcp.13125
No abstract available
Publication types
Letter
Comment
MeSH terms
Polypharmacy*